NexImmune Inc (NEXI)
0.3235
+0.10
(+46.31%)
USD |
OTCM |
Nov 14, 15:14
NexImmune Price to Book Value: 0.4902 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.335 |
| November 12, 2024 | 0.335 |
| November 11, 2024 | 0.3788 |
| November 08, 2024 | 0.3788 |
| November 07, 2024 | 0.3788 |
| November 06, 2024 | 0.3135 |
| November 05, 2024 | 0.3135 |
| November 04, 2024 | 0.3135 |
| November 01, 2024 | 0.335 |
| October 31, 2024 | 0.5606 |
| October 30, 2024 | 0.3297 |
| October 29, 2024 | 0.4047 |
| October 28, 2024 | 0.4047 |
| October 25, 2024 | 0.3297 |
| October 24, 2024 | 0.3297 |
| October 23, 2024 | 0.3598 |
| October 22, 2024 | 0.3879 |
| October 21, 2024 | 0.3809 |
| October 18, 2024 | 0.50 |
| October 17, 2024 | 0.50 |
| October 16, 2024 | 0.4848 |
| October 15, 2024 | 0.3485 |
| October 14, 2024 | 0.4091 |
| October 11, 2024 | 0.3271 |
| October 10, 2024 | 0.3562 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.3712 |
| October 08, 2024 | 0.3404 |
| October 07, 2024 | 0.3045 |
| October 04, 2024 | 0.306 |
| October 03, 2024 | 0.3182 |
| October 02, 2024 | 0.3636 |
| October 01, 2024 | 0.3712 |
| September 30, 2024 | 0.3788 |
| September 27, 2024 | 0.3788 |
| September 26, 2024 | 0.4545 |
| September 25, 2024 | 0.4821 |
| September 24, 2024 | 0.3941 |
| September 23, 2024 | 0.3788 |
| September 20, 2024 | 0.3788 |
| September 19, 2024 | 0.4545 |
| September 18, 2024 | 0.4584 |
| September 17, 2024 | 0.4017 |
| September 16, 2024 | 0.4798 |
| September 13, 2024 | 0.5757 |
| September 12, 2024 | 0.5757 |
| September 11, 2024 | 0.5379 |
| September 10, 2024 | 0.5386 |
| September 09, 2024 | 0.5303 |
| September 06, 2024 | 0.5621 |
| September 05, 2024 | 0.5621 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1128
Minimum
Dec 28 2022
5.954
Maximum
Jul 11 2024
1.283
Average
0.6653
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.065 |
| AIM ImmunoTech Inc | 2.719 |
| IGC Pharma Inc | 3.379 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.615 |
Price to Book Value Related Metrics
| Price | 0.3235 |
| Earnings Yield | -5.73K% |
| Market Cap | 0.4512M |